India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry
Airfind news item
Published on March 20, 2026.
The patent on the controversial substance, known as "modernised," has expired in India on 20th century. The managing director of Novo. . Furthermore, he expects an increase in 'Indian centennial' pricing to be made more accessible for the sake of the country.
Read Original Article
Related Articles
The Indiana University Diabetes Impact Project Helps Indy Communities
The Diabetes Impact Project, led by Lisa Staten, aims to address high diabetes rates in Indianapolis by engaging residents and leveraging low-tech techniques.
Dear Abby: We have a new baby and my wife has left me for her girlfriend
A new baby, postpartum depression, and bisexuality are causing conflict with spouses, prompting advice from a licensed mental health professional and considering legal advice.
Asking Eric: Bestie of 40+ years couldn’t be bothered to get up early to drive me to surgery. I’m done with her
A friend of 40 years, who refused to drive during a major surgery, has ended their friendship due to emotional conflicts and self-interest.